PodcastThe Directors The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access August 07, 2026Vol.52 No.31By Claire Marie Porter and Paul Goldberg
Podcast Pour a Scotch, we’re talking clinical trials and prediction markets August 05, 2026Vol.52 No.31
Podcast Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there? July 29, 2026Vol.52 No.29
PodcastThe Directors The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the wayKnudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” July 17, 2026Vol.52 No.28By Paul Goldberg and Claire Marie Porter
Podcast Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions July 15, 2026Vol.52 No.27
Podcast Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement July 01, 2026
FreePodcastThe Directors The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions” June 26, 2026Vol.52 No.25By Paul Goldberg and Claire Marie Porter
Podcast Policy by way of podcaster—FDA issues priority vouchers after Joe Rogan episode on psychedelics June 24, 2026
